1-3 of 3
Emilie Dejean
Close
Sort by
Journal Articles

ALK + ALCLs induce cutaneous, HMGB-1–dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation

Emilie Dejean, Marianne Foisseau, Fréderic Lagarrigue, Laurence Lamant, Naïs Prade, Abdelghafour Marfak, Georges Delsol, Sylvie Giuriato, Fréderique Gaits-Iacovoni, Fabienne Meggetto
Journal: Blood
Blood (2012) 119 (20): 4698–4707.
https://doi.org/10.1182/blood-2011-10-386011
Published: 2012
Includes: Supplemental data
Journal Articles

MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression

Cécile Desjobert, Marie-Hélène Renalier, Julie Bergalet, Emilie Dejean, Nicole Joseph, Anna Kruczynski, Jean Soulier, Estelle Espinos, Fabienne Meggetto, Jérome Cavaillé, Georges Delsol, Laurence Lamant
Journal: Blood
Blood (2011) 117 (24): 6627–6637.
https://doi.org/10.1182/blood-2010-09-301994
Published: 2011
Includes: Supplemental data
Journal Articles

Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia

Sylvie Giuriato, Marianne Foisseau, Emilie Dejean, Dean W. Felsher, Talal Al Saati, Cécile Demur, Ashraf Ragab, Anna Kruczynski, Claudine Schiff, Georges Delsol, Fabienne Meggetto
Journal: Blood
Blood (2010) 115 (20): 4061–4070.
https://doi.org/10.1182/blood-2008-06-163386
Published: 2010
Includes: Supplemental data